A lot of hepatitis C sufferers and their supporters protested in Madrid, complaining that public spending cuts were cutting off access to a drug that could cure the deadly liver illness.
People infected with the virus have been occupying the October 12 Hospital in southern Madrid for a week demanding the government authorise doctors to prescribe the drug more widely.
Hygiene Practices Should Improve to Control Hepatitis E Infection
Contamination Of Water And Food Persist And increases the number of death in India.
Advertisement
On Saturday several hundred patients and their backers, yelling and waving banners, took their protest to the gate of the health ministry, which they accuse of not spending enough to make the drugs available to all who need them.
"If they do not give us the latest generation medicines, we will die," said one sufferer, Antonio Fernandez, 59, at the demo by the Platform for Hepatitis C Sufferers.
![Preventing Hepatitis C Patients from Being Lost During Different Stages of Health-Care System]( "Preventing Hepatitis C Patients from Being Lost During Different Stages of Health-Care System")
Many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease, shows a new study.
The group says 12 people die each day from hepatitis C in Spain, where it estimates hundreds of thousands of people are infected.
The new hepatitis drug sofosbuvir -- marketed under the brand Sovaldi -- was approved for use in Spain in November but the group says the authorities have only spent enough to provide the drug for about 5,000 patients.
"It is trickling through," Fernandez said.
There is currently no vaccine for hepatitis C, which is caused by a virus that can be caught from contaminated blood and can lead to chronic liver disease.
A spokeswoman for Spain's health ministry told AFP that prescribing the drug depended on clinical criteria, not on budgets.
The ministry said in a statement on December 23 it was consulting experts "to ensure access for patients to the treatments they need in line with clinical criteria".
But the protest group accused officials of blocking access to sofosbuvir to save money.
"This is a very serious problem with a very simple solution. It is an economic matter," Fernandez said.
The drug has a 95 percent success rate, according to the group, but it reportedly costs tens of thousands of euros per patient.
Spain's conservative government has made tough public spending cuts in health and other sectors to stabilise the public finances in the recent economic crisis.
Spain's overall national health spending declined from 70 billion euros ($88 million) in 2009 to about 53 billion euros in 2014, according to government figures.
Source: AFP
Preventing Hepatitis C Patients from Being Lost During Different Stages of Health-Care System
Many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease, shows a new study.
Advertisement
The group says 12 people die each day from hepatitis C in Spain, where it estimates hundreds of thousands of people are infected.
The new hepatitis drug sofosbuvir -- marketed under the brand Sovaldi -- was approved for use in Spain in November but the group says the authorities have only spent enough to provide the drug for about 5,000 patients.
"It is trickling through," Fernandez said.
There is currently no vaccine for hepatitis C, which is caused by a virus that can be caught from contaminated blood and can lead to chronic liver disease.
A spokeswoman for Spain's health ministry told AFP that prescribing the drug depended on clinical criteria, not on budgets.
The ministry said in a statement on December 23 it was consulting experts "to ensure access for patients to the treatments they need in line with clinical criteria".
But the protest group accused officials of blocking access to sofosbuvir to save money.
"This is a very serious problem with a very simple solution. It is an economic matter," Fernandez said.
The drug has a 95 percent success rate, according to the group, but it reportedly costs tens of thousands of euros per patient.
Spain's conservative government has made tough public spending cuts in health and other sectors to stabilise the public finances in the recent economic crisis.
Spain's overall national health spending declined from 70 billion euros ($88 million) in 2009 to about 53 billion euros in 2014, according to government figures.
Source: AFP
Drugs That Prevent Hepatitis Among Chemotherapy Patients
Antiviral drug entecavir helps lower incidence of hepatitis B virus-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial